NEUROSCIENTIFIC BIOPHARMACEUTICALS LTDNEUROSCIENTIFIC BIOPHARMACEUTICALS LTDNEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

No trades
See on Supercharts

NSB fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing novel peptide-based pharmaceutical products. It's research and development program is focused on developing a treatment for stroke-related brain injury and dementia or Alzheimer's disease, and a diagnostic for early-stage Alzheimer's disease. The company was founded by William Harold Clough on November 14, 2002 and is headquartered in Nedlands, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
NSB has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company